Every story in this issue with a short summary, so you can decide what to read before leaving the site. Summaries are written by AI (Claude) only from each publisher's own description and checked by Jev for anything not in that description. They are not full translations. Follow "Read the original" for the full story.
Wellysis, a digital health company specializing in wearable electrocardiogram (ECG) monitoring, announced that its AI-powered ECG analysis software has received FDA 510(k) clearance.
Read the original →A PLOS Digital Health study shows that machine learning models trained on a 15-item questionnaire can screen adults for oropharyngeal dysphagia. Diagnostic accuracy approaches 0.79.
Read the original →Poursoltan and colleagues examined physician modifications to AI-generated patient messages and the associated time burden. Messages about clinical interpretations had the greatest per-message time burden, while frequent scheduling edits accounted for the most cumulative burden.
Read the original →TeleTracking Chief Clinical Executive Michelle Skinner details how closing the ambulatory visibility gap unlocks 20% in hidden clinic capacity.
Read the original →Lim said the culture of learning at NUH helps them continue to improve and adapt as health care evolves.
Read the original →The piece asks whether Ian's AI biotech stories are isolated breakthroughs or the start of something bigger. It says this week's chart offers an answer.
Read the original →AI can quickly design thousands of potential drug molecules, but whether those designs become actual medicines still depends on experimental results. As design becomes faster and cheaper, the constraint shifts downstream to who can manufacture molecules, verify their properties and supply reliable data. Freda Duan, a partner at Altimeter Capital, recently said a "bottleneck stocks" trading opportunity is emerging in AI drug discovery, similar to the trend in the AI hardware market.
Read the original →Biohub, the nonprofit research institute backed by Mark Zuckerberg and Priscilla Chan, has announced the expansion of its $1.8 billion "Virtual…
Read the original →Nobel Prize-winning computer scientist Geoffrey Hinton is calling for a major change in how AI companies bring new systems to market. He argues that developers should have to demonstrate their products are safe before releasing them to the public. Hinton is widely known as one of the pioneers of modern AI.
Read the original →Brian Anderson, M.D., says cybersecurity risk leaders are raising awareness of privacy and security issues raised by the use of agentic tools.
Read the original →An audit of four vision language models found a discrepancy between how the tools create heatmaps and how radiologists localize regions. AI has been increasingly adopted in medicine, with a marked uptake in medical imaging.
Read the original →Federal health agencies are testing AI applications that move into patient care typically handled by physicians. Recent research suggests people may place more trust in conversational AI, and false claims attributed to authoritative sources can increase willingness to share them.
Read the original →Union Square Ventures (USV) has closed its largest fund to date, at $900 million (about 140 billion yen). The partners say the essential point is not the amount.
Read the original →Dien Bien province is gradually applying artificial intelligence in healthcare through a project on using AI to build an automated system that generates PET images from CT images, to support disease diagnosis.
Read the original →